Additionally, STAT4 gene polymorphisms are at a higher risk of type 2 diabetes and systemic sclerosis (Xu et al., 2016), and STAT4 was regarded as diagnostic biomarker candidates and therapeutic targets for heart failure combined with depression (Huang et al., 2022). The gene discussed is STAT4; the disease is depressive symptom measurement.